cipla
Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted use in India
On Monday, Cipla, on behalf of the US pharma major, requested the drug regulator for import and marketing authorisation of these jabs
Cipla launches RT-PCR test kit 'ViraGen' in India partnership with Ubio Biotech
The company will commence supply of the COVID-19 virus detection kit from May 25, 2021
Gilead ties up with 5 generic drugmakers in India, Pakistan for Covid19 drug supply
The licenses are royalty-free until the World Health Organization declares the end of the public health emergency regarding Covid-19
Cipla warns of headwinds in second half after second-quarter profit miss
Shares of the company declined as much as 7.7 per cent, in their sharpest intraday drop since November 2017.
USFDA grants approval for Cipla's HIV drug
Cipla in a BSE filing said it has received final approval from USFDA for tenofovir disoproxil fumarate tablets.
Cipla Q2 profit up 19 pc on higher domestic sales
Cipla’s stock was down 5.6 per cent in Indian market that was 0.96 per cent lower.
Cipla to focus on building portfolio of respiratory products
The company will soon start looking for partners for its existing biosimilars programme, CEO Umang Vohra said at a press conference.
Cipla to form joint venture with Iranian distributor
The acquisition is expected to be completed by March 2017 subject to completion of precedent conditions and regulatory approvals.